ArticlePloS one2021
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
Dung-Tsa Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticlePloS one2021
Dung-Tsa Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.